Elisa Cappuzzello

688 total citations
17 papers, 386 citations indexed

About

Elisa Cappuzzello is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Elisa Cappuzzello has authored 17 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Elisa Cappuzzello's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Elisa Cappuzzello is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Elisa Cappuzzello collaborates with scholars based in Italy, Germany and Australia. Elisa Cappuzzello's co-authors include Antonio Rosato, Roberta Sommaggio, Matthias Peipp, Christian Kellner, Katja Klausz, Paola Zanovello, Anna Otte, Giannino Del Sal, Anna Tosi and Giovanni Sorrentino and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and European Journal of Cancer.

In The Last Decade

Elisa Cappuzzello

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Cappuzzello Italy 9 209 173 138 73 61 17 386
Carin Dahlberg Sweden 12 161 0.8× 349 2.0× 103 0.7× 91 1.2× 18 0.3× 16 494
H. Angharad Watson United Kingdom 9 154 0.7× 154 0.9× 119 0.9× 54 0.7× 15 0.2× 10 357
Mardi Fink Canada 4 164 0.8× 48 0.3× 173 1.3× 63 0.9× 22 0.4× 4 368
Mark A. Hauser Switzerland 8 232 1.1× 271 1.6× 179 1.3× 51 0.7× 43 0.7× 9 468
Karen E. Strunk United States 10 219 1.0× 215 1.2× 339 2.5× 33 0.5× 88 1.4× 11 657
Rotem Feniger-Barish Israel 10 274 1.3× 259 1.5× 168 1.2× 29 0.4× 15 0.2× 10 493
Felipe Gálvez‐Cancino Chile 11 286 1.4× 362 2.1× 136 1.0× 24 0.3× 23 0.4× 19 570
Katie E. Hebron United States 8 97 0.5× 118 0.7× 164 1.2× 44 0.6× 14 0.2× 12 348
Marsha Pellegrino Italy 13 169 0.8× 103 0.6× 212 1.5× 18 0.2× 15 0.2× 19 409
Julia Wolf United Kingdom 4 118 0.6× 52 0.3× 228 1.7× 56 0.8× 17 0.3× 6 339

Countries citing papers authored by Elisa Cappuzzello

Since Specialization
Citations

This map shows the geographic impact of Elisa Cappuzzello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Cappuzzello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Cappuzzello more than expected).

Fields of papers citing papers by Elisa Cappuzzello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Cappuzzello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Cappuzzello. The network helps show where Elisa Cappuzzello may publish in the future.

Co-authorship network of co-authors of Elisa Cappuzzello

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Cappuzzello. A scholar is included among the top collaborators of Elisa Cappuzzello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Cappuzzello. Elisa Cappuzzello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sharma, Amit, Xiubao Ren, Antonio Rosato, et al.. (2024). Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy. Cancer Immunology Immunotherapy. 73(2). 21–21. 7 indexed citations
2.
Cappuzzello, Elisa, et al.. (2023). How can Cytokine-induced killer cells overcome CAR-T cell limits. Frontiers in Immunology. 14. 1229540–1229540. 15 indexed citations
3.
Elice, Francesca, Marta Riva, M. Bernardi, et al.. (2023). Immunotherapy: AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) CELLS COMBINED WITH ANTI CD20 ANTIBODY FOR B-CELL MALIGNANCIES: FIRST REPORT ON CLINICAL FEASIBILITY. Cytotherapy. 25(6). S222–S222. 1 indexed citations
4.
Krohn, Steffen, Elisa Cappuzzello, Anja Lux, et al.. (2022). Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody. Frontiers in Immunology. 13. 957874–957874. 6 indexed citations
5.
Cappuzzello, Elisa, Andrea Visentin, Giuseppe Astori, et al.. (2021). Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. Journal for ImmunoTherapy of Cancer. 9(7). e002475–e002475. 11 indexed citations
6.
Sommaggio, Roberta, Giuseppe Astori, Katia Chieregato, et al.. (2020). A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks. Cytotherapy. 22(9). 511–518. 11 indexed citations
7.
Sommaggio, Roberta, Elisa Cappuzzello, Anna Tosi, et al.. (2020). P06.06 Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells. INFM-OAR (INFN Catania). A44.1–A44. 1 indexed citations
8.
Sommaggio, Roberta, Elisa Cappuzzello, Anna Tosi, et al.. (2020). Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells. OncoImmunology. 9(1). 1777046–1777046. 35 indexed citations
9.
Cappuzzello, Elisa, Roberta Sommaggio, Giuseppe Astori, et al.. (2020). Optimization of a gmp-grade large-scale expansion protocol for cytokine-induced killer cells using gas-permeable static culture flasks. Cytotherapy. 22(5). S116–S116. 2 indexed citations
10.
Kellner, Christian, Stefanie Derer, Katja Klausz, et al.. (2018). Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity. Methods in molecular biology. 1827. 381–397. 6 indexed citations
11.
Cappuzzello, Elisa, Roberta Sommaggio, Christian Kellner, Matthias Peipp, & Antonio Rosato. (2018). Enhancing Cytokine-Induced Killer (CIK) cell activity with Her2-specific Fc-engineered antibodies and antibody derivatives. European Journal of Cancer. 92. S23–S24. 2 indexed citations
12.
Kellner, Christian, Anna Otte, Elisa Cappuzzello, Katja Klausz, & Matthias Peipp. (2017). Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy. Transfusion Medicine and Hemotherapy. 44(5). 327–336. 81 indexed citations
13.
Tosi, Anna, Elisa Cappuzzello, Giannino Del Sal, et al.. (2017). Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. OncoImmunology. 6(8). e1313371–e1313371. 9 indexed citations
14.
Sorrentino, Giovanni, Alessandro Zannini, Rebecca Bertolio, et al.. (2017). Glucocorticoid receptor signalling activates YAP in breast cancer. Nature Communications. 8(1). 14073–14073. 128 indexed citations
15.
Cappuzzello, Elisa, Roberta Sommaggio, Paola Zanovello, & Antonio Rosato. (2017). Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells. Cytokine & Growth Factor Reviews. 36. 99–105. 43 indexed citations
16.
Cappuzzello, Elisa, Anna Tosi, Paola Zanovello, Roberta Sommaggio, & Antonio Rosato. (2016). Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies. OncoImmunology. 5(8). e1199311–e1199311. 27 indexed citations
17.
Tosi, Anna, Roberta Sommaggio, Elisa Cappuzzello, Paola Zanovello, & Antonio Rosato. (2015). Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1. 6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026